Masuda M, Miyasaka K, Funakoshi A
Department of Clinical Physiology, Tokyo Metropolitan Institute of Gerontology, Japan.
J Auton Nerv Syst. 1997 Jan 12;62(1-2):58-62. doi: 10.1016/s0165-1838(96)00109-9.
The effects of 5-hydroxytryptamine (5-HT)3 receptor antagonists (azasetron and granisetron) on basal pancreatic exocrine secretion were examined in conscious rats. Rats were prepared with cannulae draining bile and pancreatic juice separately. Intravenous injection of azasetron significantly increased pancreatic fluid and protein outputs in a dose-dependent manner. These increases were completely abolished by treatment with atropine, but not affected by bilateral truncal vagotomy. Intravenous injection of granisetron also increased pancreatic secretion, significantly. Intragastric injection of azasetron increased pancreatic secretion, although a double dose was required to elicit the stimulatory effect compared with intravenous injection. It is concluded that 5-HT3 receptor activity is involved in regulation of basal pancreatic secretion in conscious rats.
在清醒大鼠中研究了5-羟色胺(5-HT)3受体拮抗剂(阿扎司琼和格拉司琼)对基础胰腺外分泌的影响。通过分别插入引流胆汁和胰液的套管来制备大鼠。静脉注射阿扎司琼以剂量依赖的方式显著增加胰液和蛋白质的分泌量。这些增加可被阿托品治疗完全消除,但不受双侧迷走神经干切断术的影响。静脉注射格拉司琼也显著增加胰腺分泌。胃内注射阿扎司琼增加胰腺分泌,尽管与静脉注射相比需要双倍剂量才能产生刺激作用。得出结论,5-HT3受体活性参与清醒大鼠基础胰腺分泌的调节。